| Dr James Donald Baker, MD | |
|
8989 Huron St, Thornton, CO 80260-6858 | |
| (303) 853-3500 | |
| (303) 853-3702 |
| Full Name | Dr James Donald Baker |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 41 Years |
| Location | 8989 Huron St, Thornton, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053453928 | NPI | - | NPPES |
| 75922789 | Medicaid | CO |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Reach Center Inc | 4284526971 | 18 |
News Archive
Octapharma USA has submitted its Biological License Application (BLA) for octaplasLG to the U.S. Food and Drug Administration (FDA) with the goal of expanding its U.S. product portfolio by the fourth quarter of 2012.
The U.S. Food and Drug Administration has approved Fanapt tablets (iloperidone) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.
As US policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now imminent. New science can dramatically change the trajectory of both deadly epidemics, according to a special new issue of the journal Clinical Infectious Diseases.
IRIN examines the WHO's regulatory approval process for making evidence-based recommendations, noting, "Governments will generally not implement an intervention without the WHO stamp of approval."
› Verified 9 days ago
| Entity Name | Community Reach Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316906886 PECOS PAC ID: 4284526971 Enrollment ID: O20040326001266 |
News Archive
Octapharma USA has submitted its Biological License Application (BLA) for octaplasLG to the U.S. Food and Drug Administration (FDA) with the goal of expanding its U.S. product portfolio by the fourth quarter of 2012.
The U.S. Food and Drug Administration has approved Fanapt tablets (iloperidone) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.
As US policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now imminent. New science can dramatically change the trajectory of both deadly epidemics, according to a special new issue of the journal Clinical Infectious Diseases.
IRIN examines the WHO's regulatory approval process for making evidence-based recommendations, noting, "Governments will generally not implement an intervention without the WHO stamp of approval."
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Donald Baker, MD 1870 W 122nd Ave Ste 100, Westminster, CO 80234-2075 Ph: (240) 371-0259 | Dr James Donald Baker, MD 8989 Huron St, Thornton, CO 80260-6858 Ph: (303) 853-3500 |
News Archive
Octapharma USA has submitted its Biological License Application (BLA) for octaplasLG to the U.S. Food and Drug Administration (FDA) with the goal of expanding its U.S. product portfolio by the fourth quarter of 2012.
The U.S. Food and Drug Administration has approved Fanapt tablets (iloperidone) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder.
Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.
As US policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now imminent. New science can dramatically change the trajectory of both deadly epidemics, according to a special new issue of the journal Clinical Infectious Diseases.
IRIN examines the WHO's regulatory approval process for making evidence-based recommendations, noting, "Governments will generally not implement an intervention without the WHO stamp of approval."
› Verified 9 days ago
Hua Judy Chen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9141 Grant St, Ste 237, Thornton, CO 80229 Phone: 303-452-1292 Fax: 303-452-6225 | |
James Crosby, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 9141 Grant St, 237, Thornton, CO 80229 Phone: 303-452-1292 Fax: 303-452-6225 | |
Jordan Matus, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8931 Huron St, Thornton, CO 80260 Phone: 303-853-3500 | |
Dr. Abdelrahman Selim, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8931 Huron St, Thornton, CO 80260 Phone: 303-853-3500 | |
Michael Reid Mayo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8931 Huron St, Thornton, CO 80260 Phone: 303-853-3500 Fax: 303-853-3702 | |
Dr. Soyna Gulhati, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8931 Huron St, Thornton, CO 80260 Phone: 303-853-3500 |